Loading organizations...
Deuce Capital is a venture capital firm investing in pre-seed and seed-stage UK HealthTech businesses. It provides capital alongside substantial operational expertise and network access, actively mentoring founders. This hands-on strategy helps early-stage companies scale their operations and develop impactful healthcare solutions.
Established in 2024 by Branislav Trajkovski, the firm leverages his deep financial and operational background. Trajkovski's pedigree includes a Chartered Accountant role at PwC and Vice President of Tech Investment Banking at Jefferies. His experience scaling and listing a FinTech company on Nasdaq provides strategic guidance for Deuce Capital's portfolio.
Deuce Capital primarily serves UK HealthTech founders seeking strategic partnership with their investments. The firm's vision is to transform innovative concepts into sustainable, high-growth businesses, significantly advancing the healthcare sector. It actively cultivates a new generation of successful health technology enterprises.
Deuce Capital has 1 tracked investment across 1 company. The latest tracked deal is $2.7M Seed in Punto Health in December 2025.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Dec 14, 2025 | Punto Health | $2.7M Seed | — | Enrique Linares Plaza, Abac Nest, Exceptional Ventures, Fondo Bolsa Social, Heartfelt, Lavender Ventures, Tomás Güida |
